The Melanoma Research Alliance has announced grants worth $5.2m to support six multidisciplinary teams’ work on improving treatment approaches for metastatic melanoma.

The work including studies of immunotherapies and molecularly targeted therapies.

The Melanoma Research Alliance is a public charity formed to support research into melanoma, of which 132,000 new cases are diagnosed across the world each year.